Caring for Patients with Mesothelioma: Principles and Guidelines [electronic resource] /
Hesdorffer, Mary.editor.
Bates-Pappas, Gleneara E.editor.
This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.
Chapter 1: The history of Mesothelioma and medical research -- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery -- Chapter 3: History of Pleural surgical treatment -- Chapter 4: History of clinical trials -- Chapter 5: Caring for patients undergoing pleural surgery -- Chapter 6: Peritoneal Treatment -- Chapter 7: Radiation Therapy -- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy -- Chapter 9: Caring for patients during and after Immunotherapy treatment -- Chapter 10: Biotherapy treatment -- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab -- Chapter 12: Physical therapy -- Chapter 13: Occupation therapy -- Chapter 14: Nutrition -- Chapter 15: Mental health treatment -- Chapter 16: Pain Management -- Chapter 17: Palliative Care -- Chapter 18: Long Term care and Survivorship -- Chapter 19: End- of-Life care -- Chapter 20: Patient perspective on mesothelioma treatment -- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use -- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact? -- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia -- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials -- Chapter 25: Basic Science Research -- Chapter 26: Genetics and Genetic Counseling -- Part VI: Patient's perspective_Chapter 27: Patient involment in research -- Chapter 28: The development of mesothelioma foundations and patient support -- Chapter 29: The impact of social media mesothelioma.
This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.
Nursing.
Oncology  .
Respiratory organs—Diseases.
Nursing.
Oncology.
Pneumology/Respiratory System.